China Must Ensure Safety Is Paramount in Biotech Push, says AHF
14 Apr 2023
LOS ANGELES--(BUSINESS WIRE)--A Washington Post investigation has revealed an ambitious effort by China to expand its biotechnology sector significantly, with sometimes controversial research, to keep up with (or overtake) the U.S. and other Western powers while failing to ensure adequate safety measures kept pace. AIDS Healthcare Foundation (AHF) urges China or any nation conducting research with dangerous, highly-infectious pathogens to ensure the utmost security and oversight measures are implemented beforehand.
'The news of China\u2019s move to dramatically increase its biotech sector, including genetic engineering, without first ensuring ample security measures is beyond worrisome \u2013 it\u2019s irresponsible and potentially endangers everyone worldwide'
“The news of China’s move to dramatically increase its biotech sector, including genetic engineering, without first ensuring ample security measures is beyond worrisome – it’s irresponsible and potentially endangers everyone worldwide,” said Dr. Adele Schwartz Benzaken, AHF Senior Global Medical Director. “We implore China to do the right thing by ensuring an adequate portion of the billions of dollars it’s putting into increased laboratories, research, and experimental medicines goes to commensurate security that will bolster defenses against serious lab accidents – like the leaked bacteria that cause brucellosis in 2019 in Lanzhou and potentially SARS-CoV-2 in Wuhan the same year, which remains to be seen. The world cannot afford another pandemic unleashed upon it.”
About AIDS Healthcare Foundation (AHF)
AIDS Healthcare Foundation, the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.